Author Topic: (JAMA editorial) Linking genotype to clinical phenotype in MS  (Read 109 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
JAMA Neurology May 31, 2016) contains an article by researchers at the University of California, "Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis." The entire article can be seen here.

There is also an editorial in the same issue of JAMA Neurology, by two physicians from Yale University, "Linking genotype to clinical phenotype in multiple sclerosis: In search of the Holy Grail":

http://app.jamanetwork.com/#page=issuesContainer
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
139 Views
Last post October 30, 2016, 03:32:06 pm
by agate
1 Replies
142 Views
Last post January 19, 2019, 05:30:20 pm
by agate
0 Replies
171 Views
Last post August 26, 2019, 04:45:30 pm
by agate
0 Replies
38 Views
Last post September 05, 2021, 09:58:35 pm
by agate
0 Replies
28 Views
Last post December 20, 2022, 09:08:02 pm
by agate